AML PIA Evaluation (ID: i708) Question Title * 1. Which of the following best describes the impact of this activity on your performance? I will implement the information in my area of practice. I need more information before I change my practice behavior. This activity will not change my practice, as my current practice is consistent with the information presented. This activity will not change my practice, as I do not agree with the information presented. Question Title * 2. How committed are you to making changes in your practice based on your participation in this activity? Very committed Committed Neutral Not committed I do not plan to make changes. Question Title * 3. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice? Question Title * 4. What barriers do you see to making changes in your practice? Question Title * 5. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities: For questions 6-9, please rate your level of agreement by checking the appropriate rating. Question Title * 6. After participating in today’s activity, I am now able to: Strongly agree Agree Neutral Disagree Strongly disagree Describe the pathophysiology of AML and identify potential therapeutic targets Describe the pathophysiology of AML and identify potential therapeutic targets Strongly agree Describe the pathophysiology of AML and identify potential therapeutic targets Agree Describe the pathophysiology of AML and identify potential therapeutic targets Neutral Describe the pathophysiology of AML and identify potential therapeutic targets Disagree Describe the pathophysiology of AML and identify potential therapeutic targets Strongly disagree Summarize current clinical trial evidence regarding the efficacy and safety of new and emerging therapies for AML Summarize current clinical trial evidence regarding the efficacy and safety of new and emerging therapies for AML Strongly agree Summarize current clinical trial evidence regarding the efficacy and safety of new and emerging therapies for AML Agree Summarize current clinical trial evidence regarding the efficacy and safety of new and emerging therapies for AML Neutral Summarize current clinical trial evidence regarding the efficacy and safety of new and emerging therapies for AML Disagree Summarize current clinical trial evidence regarding the efficacy and safety of new and emerging therapies for AML Strongly disagree Outline an approach to AML treatment selection that is tailored based upon individual patient characteristics Outline an approach to AML treatment selection that is tailored based upon individual patient characteristics Strongly agree Outline an approach to AML treatment selection that is tailored based upon individual patient characteristics Agree Outline an approach to AML treatment selection that is tailored based upon individual patient characteristics Neutral Outline an approach to AML treatment selection that is tailored based upon individual patient characteristics Disagree Outline an approach to AML treatment selection that is tailored based upon individual patient characteristics Strongly disagree Question Title * 7. Jorge E. Cortes, MD, effectively: Strongly agree Agree Neutral Disagree Strongly disagree Presented the material Presented the material Strongly agree Presented the material Agree Presented the material Neutral Presented the material Disagree Presented the material Strongly disagree Avoided commercial bias Avoided commercial bias Strongly agree Avoided commercial bias Agree Avoided commercial bias Neutral Avoided commercial bias Disagree Avoided commercial bias Strongly disagree Question Title * 8. Richard M. Stone, MD, effectively: Strongly agree Agree Neutral Disagree Strongly disagree Presented the material Presented the material Strongly agree Presented the material Agree Presented the material Neutral Presented the material Disagree Presented the material Strongly disagree Avoided commercial bias Avoided commercial bias Strongly agree Avoided commercial bias Agree Avoided commercial bias Neutral Avoided commercial bias Disagree Avoided commercial bias Strongly disagree Question Title * 9. The content presented: Strongly agree Agree Neutral Disagree Strongly disagree Enhanced my current knowledge base Enhanced my current knowledge base Strongly agree Enhanced my current knowledge base Agree Enhanced my current knowledge base Neutral Enhanced my current knowledge base Disagree Enhanced my current knowledge base Strongly disagree Addressed my most pressing questions Addressed my most pressing questions Strongly agree Addressed my most pressing questions Agree Addressed my most pressing questions Neutral Addressed my most pressing questions Disagree Addressed my most pressing questions Strongly disagree Promoted improvements or quality in health care Promoted improvements or quality in health care Strongly agree Promoted improvements or quality in health care Agree Promoted improvements or quality in health care Neutral Promoted improvements or quality in health care Disagree Promoted improvements or quality in health care Strongly disagree Was scientifically rigorous and evidence based Was scientifically rigorous and evidence based Strongly agree Was scientifically rigorous and evidence based Agree Was scientifically rigorous and evidence based Neutral Was scientifically rigorous and evidence based Disagree Was scientifically rigorous and evidence based Strongly disagree Avoided commercial bias or influence Avoided commercial bias or influence Strongly agree Avoided commercial bias or influence Agree Avoided commercial bias or influence Neutral Avoided commercial bias or influence Disagree Avoided commercial bias or influence Strongly disagree Question Title * 10. If you indicated that you perceived commercial bias or influence, please describe: Question Title * 11. How would you rate the format of this activity? Excellent Average Below average Poor Question Title * 12. Disclosure of any relevant financial relationships of the presenters and planners was made prior to the activity. Yes No Question Title * 13. Would you be willing to participate in a postactivity follow-up survey? Yes No Question Title * 14. Would you like to be contacted about future educational activities in your area of practice? Yes No Done